-
1
Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
Published 2021-06-01Subjects: Get full text
Article -
2
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
Published 2024-12-01Subjects: Get full text
Article -
3
Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Ye...
Published 2021-01-01Subjects: “…pneumococcal disease…”
Get full text
Article -
4
Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006–2015
Published 2020-12-01Subjects: “…Invasive pneumococcal disease…”
Get full text
Article -
5
Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
Published 2023-01-01Subjects: Get full text
Article -
6
Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012–2024
Published 2024-12-01Subjects: Get full text
Article -
7
An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
Published 2024-12-01Subjects: “…Pneumococcal disease…”
Get full text
Article -
8
Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysacchari...
Published 2019-04-01Subjects: “…pneumococcal disease…”
Get full text
Article -
9
Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
Published 2023-05-01Subjects: “…pneumococcal disease…”
Get full text
Article -
10
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
Published 2023-08-01Subjects: “…pneumococcal disease…”
Get full text
Article -
11
Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis
Published 2024-05-01Subjects: “…Pneumococcal disease…”
Get full text
Article -
12
The Economic Burden of Pneumococcal Disease in Children: A Population-Based Investigation in the Veneto Region of Italy
Published 2022-09-01Subjects: “…pneumococcal disease…”
Get full text
Article -
13
Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs
Published 2024-12-01Subjects: “…Pneumococcal disease…”
Get full text
Article -
14
Approaches to vaccination of adults against pneumococcal disease in different countries of the world
Published 2024-07-01Subjects: Get full text
Article -
15
Association between asthma and invasive pneumococcal disease risk: a systematic review and meta-analysis
Published 2020-11-01Subjects: Get full text
Article -
16
-
17
Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
Published 2019-11-01Subjects: Get full text
Article -
18
Immunochromatographic method in the diagnosis of pneumococcal respiratory tract diseases
Published 2014-09-01Subjects: “…pneumococcal disease…”
Get full text
Article -
19
Invasive Pneumococcal Disease Case Series in Pediatric Inpatients: A Clinical Experience from South India
Published 2022-03-01Subjects: “…invasive pneumococcal disease…”
Get full text
Article -
20
Pediatric cases caused by Streptococcus pneumoniae Serotype 3
Published 2019-04-01Subjects: “…invasive pneumococcal disease…”
Get full text
Article